首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1799570篇
  免费   132813篇
  国内免费   2994篇
耳鼻咽喉   26042篇
儿科学   55496篇
妇产科学   49814篇
基础医学   257269篇
口腔科学   51958篇
临床医学   159152篇
内科学   340598篇
皮肤病学   38720篇
神经病学   140782篇
特种医学   71855篇
外国民族医学   370篇
外科学   277309篇
综合类   43314篇
现状与发展   3篇
一般理论   508篇
预防医学   133323篇
眼科学   42478篇
药学   140576篇
  7篇
中国医学   4075篇
肿瘤学   101728篇
  2018年   17311篇
  2016年   15446篇
  2015年   17577篇
  2014年   24565篇
  2013年   36502篇
  2012年   49620篇
  2011年   52325篇
  2010年   30664篇
  2009年   28792篇
  2008年   48829篇
  2007年   52641篇
  2006年   53096篇
  2005年   51246篇
  2004年   49657篇
  2003年   47691篇
  2002年   46065篇
  2001年   86850篇
  2000年   88953篇
  1999年   74728篇
  1998年   20059篇
  1997年   18033篇
  1996年   17967篇
  1995年   16910篇
  1994年   15748篇
  1993年   14908篇
  1992年   59285篇
  1991年   57492篇
  1990年   56515篇
  1989年   54571篇
  1988年   50124篇
  1987年   49078篇
  1986年   46418篇
  1985年   44233篇
  1984年   32974篇
  1983年   28160篇
  1982年   16559篇
  1981年   14790篇
  1979年   31499篇
  1978年   21970篇
  1977年   19141篇
  1976年   17045篇
  1975年   19004篇
  1974年   22871篇
  1973年   21994篇
  1972年   21004篇
  1971年   19626篇
  1970年   18407篇
  1969年   17882篇
  1968年   15999篇
  1967年   14538篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
Objective: Human epidermal growth factor receptor 2 (erbb2/HER2) overexpression, has now been implicatedin advanced gastric and gastroesophageal junction cancers. The study was conducted to determine the rate of HER2positivity in patients with locally advanced or metastatic gastric and gastroesophageal adenocarcinoma in North-EastIndia and to assess the impact of various demographic and clinical parameters on HER2 positivity. Methods: A total of68 patients of age >18 years of gastric and gastroesophageal adenocarcinoma diagnosed on histopathological examinationfrom September 2016 to February 2018 at Dr B Borooah Cancer Institute, Assam were enrolled for the observational(epidemiological) study. All patients were subjected to the HER2 immunohistochemistry test using a FDA-approved,standardized test kit. HER2 expression was correlated with various demographic and clinicopathological parameters.Results: The overall rate of HER2 positivity in the population studied was 56% (n=38). The rate was non-significantlyhigher in male, older age group (>60 years) and Hindu population. Similarly, HER2 positivity rate was higher in patientswith well differentiated histology and was more common in patients with stage II and III diseases, but neither of theassociations is statistically significant. HER2 positivity rate was significantly higher in proximal and in GEJ tumours(56% versus 44%, P=0.002). Conclusion: HER2 overexpression was evident in 56% of the North-East Indian patientswith locally advanced and metastatic gastric and gastroesophageal adenocarcinoma. The overexpression correlatedsignificantly with primary tumour site. Routine testing of gastric and gastroesophageal tumours for HER2 expressionis recommended to provide a therapeutic advantage in Indian patients.  相似文献   
35.
36.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
37.
38.
39.
40.
We report on a child with several café au lait spots in association with a lumbar lipomeningomyelocele as an apparently new association. Cutaneous markers, the identification of which plays a crucial role in the early diagnosis and management of spinal malformations, can accompany occult spinal dysraphism. Herein we report a case of lumbar lipomeningomyelocele associated with an overlying café au lait spot that served as a marker of occult spinal dysraphism. The patient also had segmental café au lait spots on the face, making the association unique.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号